Follicular Lymphoma International Prognostic Index (FLIPI) 24
Assesses 24-month event risk in patients with follicular lymphoma (FL) starting first-line immunochemotherapy.
Advice
Scores should be interpreted alongside clinical judgment, disease burden, patient performance status, and treatment goals.
- Use results to guide prognosis and treatment discussions with patients.
- Patients with elevated risk could be considered for novel therapies or clinical trial enrollment.